Electromagnetic redesign of the HYPERcollar applicator: towards improved deep local head-and-neck hyperthermia *P. Togni, Z. Rijnen, W.C.M. Numan, R.F.

Slides:



Advertisements
Similar presentations
Barbara Vanderstraeten Ghent University Hospital 19 January 2008
Advertisements

MR Image Guided Hyperthermia Gerhard Sennewald PhD, Munich, Germany Kazakh Medical Diagnostic Forum “Technological Innovations in radiology & functional.
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer CCOP Investigators’
Hyperthermia Applicator for Small Superficial Tumour Treatment Paolo TOGNI 1,Jan VRBA 1, Luca VANNUCCI 2 1 Dept. of EM Field, Czech Technical University.
Biologiske modeller i stråleterapi Dag Rune Olsen, The Norwegian Radium Hospital, University of Oslo.
Clinical Significance of Preoperative 18F-FDG PET Non- Avidity in Papillary Thyroid Carcinoma Do Hoon Koo 1, Ho-Young Lee 2, Kyu Eun Lee 3,4, So Won Oh.
Slice Thickness Interpolation: The effect of interpolated slice thickness on the 2D vs 3D gamma results are shown in Table 3 for the QA data set only.
Is mammacarcinoom onder de veertig jaar morfologisch en genetisch een andere ziekte? Marc van de Vijver, Netherlands Cancer Institute, Amsterdam, NL.
Departments - Surgery - Gerontology and Geriatrics Department of SurgeryDepartment of Gerontology & Geriatrics Prof. dr. C.J.H. van de VeldeProf. dr. R.G.J.
Carbon Nanotubes as a Heating Agent in Microwave Ablation Introduction: Microwave Ablation (MWA) is a technique for ablating tumors using microwave frequency.
Background:  IMRT has become the choice of treatment for disease sites that require critical structure sparing such as head and neck cancer.  It has.
1 Improved critical structure sparing with biologically based IMRT optimization X.Sharon Qi, Vladimir A. Semenenko and X. Allen Li Department of Radiation.
HIGHLIGHTS IN THE MANAGEMENT OF BREAST CANCER
Successful treatment of pediatric desmoid tumors using hydroxyurea Naomi Balamuth, M.D. Richard Womer, M.D. November 13, 2008.
Gamma Knife Surgery and Region Covering Aaron Epel.
IMPROVED BREAST CANCER DIAGNOSIS AND PROGNOSIS BY
METHODS This project is an evidence based literature review conducted using the databases of Medline, AbstractsFirst, and Cochrane. The search terms used.
New York University Department of Radiation Oncology A Phase I-II Study of Adjuvant Concurrent Carboplatin and Accelerated Radiotherapy for Triple Negative.
M. Wissmeyer Department of Nuclear Medicine, University of Berne (Inselspital) PET/CT in Radiation Oncology: Current Evidence and Future Perspectives.
Parameter selection in prostate IMRT Renzhi Lu, Richard J. Radke 1, Andrew Jackson 2 Rensselaer Polytechnic Institute 1,Memorial Sloan-Kettering Cancer.
Vincent Grégoire, Peter Levendag et. al. DELINEATION OF THE CTV IN THE N 0 NECK OF PATIENTS WITH HEAD & NECK SQUAMOUS CELL CARCINOMA. ANATOMICAL BOUNDARIES.
M. Yoda, S. I. Abdel-Khalik, D. L. Sadowski and M. D. Hageman Woodruff School of Mechanical Engineering Update on Thermal Performance of the Gas- Cooled.
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
10 Minutes Talk 吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Sep 08, 2008.
MODEGAT Chalmers University of Technology Use of Latent Variables in the Parameter Estimation Process Jonas Sjöblom Energy and Environment Chalmers.
Low dose chemotherapy with insulin (Insulin Potentiation Therapy) in combination with hormone therapy for treatment of castration resistant prostate cancer.
Influence of the size of the cohorts in adaptive design for nonlinear mixed effect models: an evaluation by simulation for a pharmacokinetic (PK) and pharmacodynamic.
How to achieve a homogeneous sensitivity in THz detector arrays
Ischemic Heart Disease Following Left Breast Irradiation with Active Breathing Control (ABC): 10 year Outcomes and Risk Modeling Abstract 1027 Presenter:
Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.
BREAST MRI IN RADIATION THERAPY PLANNING MARSHA HALEY, M.D. ASSISTANT PROFESSOR UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PENNSYLVANIA, USA.
Insert Program or Hospital Logo Introduction Melanoma is notoriously resistant to chemotherapy. While surgical resection and adjuvant chemotherapy can.
IMRT QA Plan Site 5%/3mm3%/3mm2%/2mm 0% noise1% noise2% noise0% noise1% noise2% noise0% noise1% noise2% noise HN
Ye, Sung-Joon, Ph.D. Ove, Roger, M.D., Ph.D.; Shen, Sui, Ph.D.
HER2 POSITIVE BREAST CARCINOMA IN THE PRE AND POST ADJUVANT ANTI-HER-2 THERAPY ERA: A SINGLE ACADEMIC INSTITUTION EXPERIENCE IN THE SETTING OUTSIDE OF.
Cancer Disparities Research Partnership (CDRP): Linking University & Community Radiation Oncology to Improve Cancer Outcomes Patrick D. Maguire, M.D. New.
Universiteit Antwerpen Conference "New Frontiers in Evaluation", Vienna, April 24th-25th Reliability and Comparability of Peer Review Results Nadine.
Integrating a Molecular Signature of Intrinsic Radiosensitivity into the Classification of Breast Cancer J. F. Torres-Roca, W. J. Fulp, A. O. Naghavi,
K. Pulliam, MS 1,2., D Followill, PhD 2., L Court, PhD 2., L Dong, PhD 3., M Gillin, PhD 2., K Prado, PhD 3., S Kry, PhD 2 1 The University of Texas Graduate.
UNIVERSITY OF PATRAS ELECTRICAL & COMPUTER ENG. DEPT. LABORATORY OF ELECTROMAGNETICS A Hybrid Electromagnetic-Discrete Multipath Model for Diversity Performance.
Institute of Nuclear Engineering and Science National Tsing Hua University Institute of Nuclear Engineering and Science National Tsing Hua University BNCT.
Improvement of the Monte Carlo Simulation Efficiency of a Proton Therapy Treatment Head Based on Proton Tracking Analysis and Geometry Simplifications.
Journal Club Dept. Of Medical Physics Faculty of Medicine Iran Uni. Of Medical Sciences Hyperthermia SR Mahdavi 1395/07/27.
FINANCIAL IMPACT OF JUDICIOUS USE OF MEDICINE IN PRIMARY CARE Zuo, Yeqin; Morrell, Stephen; Dartnell, Jonathan; Wu Fred; Weekes, Lynn NPS: Better Choices,
S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients.
Karolina Kokurewicz Supervisors: Dino Jaroszynski, Giuseppe Schettino
Experimental Cave at Trento CPT: status update Francesco Tommasino RDH/IRPT Meeting – Roma, 1 Feb 2016.
The use of Radiotherapy in Cancer.. What is radiotherapy? The treatment of cancer with ionising radiation is called Radiotherapy or Radiation Oncology.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Chapter 12 Therapeutic Heating Applications of Radio Frequency Energy C-K. Chou.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
The HiLumi LHC Design Study is included in the High Luminosity LHC project and is partly funded by the European Commission within the Framework Programme.
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, Maggio 2016.
Beam specific PTV incorporating 4DCT for PBS proton therapy of thoracic tumors Minglei Kang, PhD Authors: Liyong Lin1*, Minglei Kang1*, Sheng Huang1,
Dr. Malhar Patel DNB (Radiation Oncology)
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Radiofrequency ablation combined with hypertonic saline injection allows creation of coagulation zones similar to those created by microwave ablation Quesada,
International Workshop on radiosensitization
Comparison of carina- versus bony anatomy-based registration for setup verification in esophageal cancer image-guided radiotherapy Melanie Machiels* 1,
Y. Yan1, V. Adhikarla1, M. W. Kissick1,2, D. Campos1, D. H. Zhao1, S
Case presented by Dr Moriarty
Figure 2 Multiscale modelling in oncology
L. A. den Otter. , R. M. Anakotta. , M. Dieters. , C. T. Muijs. , S
UOG Journal Club: August 2013
Stamatia Destounis, MD, FACR, FSBI, FAIUM
HISTOLOGY-SPECIFIC NOMOGRAM FOR PATIENTS AFFECTED BY PRIMARY RSTS
Generation of Uniform Magnetic Field for Cancer Hyperthermia Research
MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen. MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients.
Presentation transcript:

Electromagnetic redesign of the HYPERcollar applicator: towards improved deep local head-and-neck hyperthermia *P. Togni, Z. Rijnen, W.C.M. Numan, R.F. Verhaart, J.F. Bakker, G.C. van Rhoon and M.M. Paulides Journal Club * Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands Grant DDHK Submitted to : Physics in Medicine and Biology

Content  Introduction  Methods  Results  Discussion  Conclusion

Introduction Research question:  Can we improve treatment quality with a new antenna arrangement? Goal:  Evaluate quality improvements using a new antenna arrangement implemented in a mechanically redesigned HYPERcollar: hot-spot target coverage heating capability

Methods: applicator models

clinical experience Methods: applicator models

clinical experience 12 antennas 2 rings circular array arrangement bulging WB Methods: applicator models

clinical experience 12 antennas 2 rings circular array arrangement bulging WB 20 antennas 3 rings ‘horse-shoe’’ array arrangement bulging WB Methods: applicator models

clinical experience 12 antennas 2 rings circular array arrangement bulging WB 20 antennas 3 rings ‘horse-shoe’’ array arrangement bulging WB 20 antennas 3 rings ‘horse-shoe’’ array arrangement reduced diameter flat-end WB Methods: applicator models

current study clinical experience 12 antennas 2 rings circular array arrangement bulging WB 20 antennas 3 rings ‘horse-shoe’’ array arrangement bulging WB 20 antennas 3 rings ‘horse-shoe’’ array arrangement reduced diameter flat-end WB Methods: applicator models

Methods: patient inclusion first 26 patient treated with HYPERcollar applicator

Methods: optimization and evaluation parameters: Hotspot importance : Tumor coverage : Target heating capability : o mean SAR in target o max theoretical system power (antenna use uniformity)

Results: ‘ horse-shoe’ array arrangement justification HYPERcollar model (I)

Results: ‘ horse-shoe’ array arrangement justification Limited contribution of dorsal antenna (< 0.16) Indirect contribution via the head-rest  high sensitivity to slight off-sets  dorsal antenna excluded from HYPERcollar (I) optimizations HYPERcollar model (I)

Results: hot-spot reduction (HTQ) tumor coverage (TC25)

-27 %-32 % ‘Horse-shoe’’ layout introduce a importance reduction

Results: hot-spot reduction (HTQ) tumor coverage (TC25) -27 %-32 % +3 % +2 % Limited improvement of coverage when used as optimization function

Results: hot-spot reduction (HTQ) tumor coverage (TC25) -27 %-32 % 59 % 81% 73% Coverage improvement for worst cases  “hard to heat” patients

Results: mean SAR target (Pin = 1W)

+53% +170 %

Results: mean SAR target (Pin = 1W) +53% +170 % +34% +112 %

Results: mean SAR target (Pin = 1W) +53% +170 % +34% +112 % New desing over-perform modified HYPERcollar  reduced back plane diameter (400 mm  320 mm)

Results: maximum system power

+59% +62%

Results: maximum system power +59% +62% +28%+37%

Results: maximum system power +59% +62% +28%+37% Applicators with “horse-shoe’’ perform better  more uniform contribute of antennas

Discussion  new array arrangement alone substantially reduce hotspot importance  (HTQ -27% model II, HTQ -32% model III)  increased number of antennas produce a better power focusing  in agreement with *Paulides et al and **Trefna et al  possibility to choose 12 antennas out of 20 allow a more uniform antenna use  reduced probability of power to be treatment limiting  reduced ground plane diameter allowed better focus capability  in agreement with *Paulides et al * Paulides et al Int. J. Hyperthermia 23(1): 59–67 **Trefna et al Int. J. Hyperthermia 26(2): 185–197.

Discussion  new design did not outperformed mod. HYPERcollar in TC25  bulging WB allow a better power deposition in targets extending outside applicator ground plane (6/8 ‘neck’ patients)  bulging WB has low reproducibility  increased treatment quality variation in clinic.  solution applicator tilted 30° for ‘neck’ patients  WB extensions in caudal direction to be investigated

Discussion  two SAR-based optimization function were used (HTQ + TC25) because a quality parameter predictive for H&N HT outcome was not established yet: HTQ: best correlate with T50 in DHT (*Canters et al. 2009) TC25: target totally cover by 25% iso-SAR best factor for prediction clinical outcome in recurrent breast carcinoma (**Myerson et al. 1990, ***Lee et al. 1998)  both are used to prove robustness of new design for H&N HT * Canters et al. 2009, Phys Med Biol 54: 3923–3936. ** Myerson et al. 1990, Int J Radiat Oncol Biol Phys 18(5): 1123–1129 *** Lee et al. 1998, Int J Radiat Oncol Biol Phys 40(2): 365–375

Discussion  uncertainties evaluation in HT simulation studies: SAR patterns robustness to patient positioning variations in DHT (*Canters et al. 2009) role dielectric and perfusion uncertainties on HTP (**de Greef et al. 2010)  In our case large number of patients (26) with targets in different locations represents an ‘anatomy-based’ uncertainties evaluation  more relevant to verify heating capability improvement and design robustness * Canters et al. 2009, Phys Med Biol 54: 3923–3936. ** de Greef et al Med Phys 37(9): 4540–4550.

Conclusions  HYPERcollar array arrangement sub-optimaI  limited contribution of dorsal antennas  “Horse-shoe” array arrangement integrated in mechanical redesign  hot-spot : – 32 % (HTQ)  target coverage : + 2 % (TC25)  focus capability : > % (mean SAR target [1W ])  max system power : 981 W (+49 %)  Substantial improvement theoretical H&N treatment quality  Combination with mechanical redesign improved reproducibility  expected strong improvement in clinical treatment quality

Thank you for you attention questions? Grant DDHK